Signals to Certainty™ is a framework developed by Our Fertile Future® to help people understand and confidently navigate the strength of evidence behind the many factors that impact fertility, including environmental, lifestyle, systemic, and psychosocial factors.

The framework uses a clear three-tiered classification — Established, Indicated, and Emerging — to translate complex research into practical categories for individuals, couples, and professionals navigating high-stakes fertility-related decisions.

In short: Every finding gets graded based in how strongly supported it is by available evidence. Jump to the breakdown ↓

This is the research-led framework behind everything we share, whether it shows up as evidence-informed advocacy or research-directed action.

The goal of the Signals to Certainty framework is to bring both the evidence and the priority of potential interventions into clearer focus, so that you can make informed, values-based choices that align with your personal goals and your natural level of caution.

The framework is grounded in rigorous scientific principles and draws inspiration from systems such as the WHO’s IARC classifications, the U.S. EPA’s risk tiers, and the GRADE evidence rating scale. However, it is distinct in its focus, language, and application to factors affecting reproductive health.

The Signals to Certainty™ framework is shared under a Creative Commons Attribution–NonCommercial–NoDerivatives (CC BY-NC-ND) license. You are welcome to use and share the framework for non-commercial purposes, with attribution to Our Fertile Future®. Modification or adaptation is not permitted.

The Three Tiers of Evidence

1. Established Evidence

Definition:
The finding is backed by a robust and consistent body of high-quality scientific research, with strong agreement across multiple independent studies, and often supported by regulatory and clinical consensus. Causality is well understood or widely accepted within the scientific community.

Criteria:

  • Meta-analyses or systematic reviews of high-quality human studies
  • Strong biological plausibility and demonstrated mechanisms
  • Replicated findings across diverse populations and study designs
  • Often, but not necessarily, broad agreement from authoritative bodies (e.g. WHO, EPA, Endocrine Society)

Examples:

  • Lead exposure associated with increased risk of infertility, miscarriage and stillbirth
  • Organophosphate pesticides are consistently linked to reduced sperm concentration, motility and morphology 
  • BPA exposure associated with reduced sperm concentration, lower motility, increased DNA fragmentation, and abnormal morphology
  • Phthalate exposure linked to impaired sperm function, reduced ovarian reserve, and poorer IVF outcomes

Implications:
Established evidence supports regulatory policy, clinical guidance, and widespread public health action. Failing to act in these cases risks ethical and health consequences.

2. Indicated Evidence

Definition:
The evidence base is moderate to strong, with consistent associations observed in human studies and supportive mechanistic or animal data. Causality is biologically plausible, and gaining recognition from expert groups within the scientific community, though not yet universally confirmed or regulated.

Criteria:

  • Multiple well-conducted human studies showing similar trends
  • Strong mechanistic evidence, even if causal chains are not fully established
  • Growing agreement among expert groups or within specific research domains
  • Potential variability in study size, design, or population

    Examples:

    • Mercury exposure associated with increased infertility risk in women, poorer semen quality in men and increased miscarriage and adverse birth outcomes
    • Organophosphate pesticide exposure has been associated with a fecundability odds ratio of approximately 0.46: roughly half the probability of conception per cycle compared to unexposed couples
    • BPA linked to implantation failure and sporadic and recurrent miscarriage risk
    • Phthalate exposure associated with increased risk of early miscarriage, with studies showing dose dependant relationships

    Implications:
    Indicated evidence justifies precautionary choices, targeted risk communication, and policy attention. Many progressive clinicians and public health advocates act at this level to reduce risk in vulnerable populations.

    3. Emerging Evidence

    Definition:
    The evidence is preliminary or limited, often based on early-stage, small-scale, or animal/in vitro studies. Associations are biologically plausible but not yet proven. These findings are early signals. It’s worth noting that reproductive and environmental health research is chronically underfunded relative to its public health significance, so a genuine signal can remain at this tier for decades, not because the effect isn’t real, but because no one has funded the studies that would confirm it.

    Criteria:

    • May include initial human data with small sample sizes or limited controls
    • Mostly animal or mechanistic studies supporting plausible pathways
    • No formal regulatory classification yet; scientific debate ongoing
    • Limited replication and still evolving

    Examples:

    • BPA substitutes (BPS/BPF) may have similar or potentially greater effects on male reproductive parameters than BPA and are linked to adverse effects on eggs and ovarian function
    • BPA may disrupt fertility through epigenetic modifications that impact future generations
    • Phthalates and Pesticides (several classes) show reproductive effects that persist across generations without ongoing exposure

    Implications:
    Emerging evidence warrants ongoing research, monitoring, and public awareness, particularly in high-stakes contexts like preconception, pregnancy, and early childhood development.

    Risk-aware individuals, parents, and practitioners may choose to act even at this early stage, especially when:

    • The potential harm is irreversible, or may impact multiple future generations
    • Exposure is widespread or hard to avoid without taking deliberate, intentional action
    • Alternatives are low-cost, low-risk, or have additional benefits

    This aligns with the precautionary principle: it’s better to act on a credible, early signal than wait for absolute certainty when delay could lead to harm.

    Summary Table With Example Findings

    TierNameEvidence TypeExample FindingsSuggested Response
    1Established (Est)Conclusive human evidence, often with regulatory/clinical consensusLead exposure associated with increased risk of infertility, miscarriage and stillbirth

    Organophosphate pesticides are consistently linked to reduced sperm concentration, motility and morphology 

    BPA exposure associated with reduced sperm concentration, lower motility, increased DNA fragmentation, and abnormal morphology

    Phthalate exposure linked to impaired sperm function, reduced ovarian reserve, and poorer IVF outcomes
    Regulatory action, clinical guidance, public warning
    2Indicated (Ind)Moderately strong evidence, plausible causalityMercury exposure associated with increased infertility risk in women, poorer semen quality in men and increased miscarriage and adverse birth outcomes

    Organophosphate pesticide exposure has been associated with a fecundability odds ratio of approximately 0.46: roughly half the probability of conception per cycle compared to unexposed couples

    BPA linked to implantation failure and sporadic and recurrent miscarriage risk

    Phthalate exposure associated with increased risk of early miscarriage, with studies showing dose dependant relationships
    Precaution, targeted education, professional vigilance
    3Emerging (Emg)Early-stage, limited, or preclinical evidenceBPA substitutes (BPS/BPF) may have similar or potentially greater effects on male reproductive parameters than BPA and are linked to adverse effects on eggs and ovarian function

    BPA may disrupt fertility through epigenetic modifications that impact future generations

    Phthalates and Pesticides (several classes) show reproductive effects that persist across generations without ongoing exposure
    Awareness, voluntary action, further study

    Tiered evidence systems are commonly used in medicine, public health, and toxicology; however they are often fragmented across disciplines and difficult for non-specialists to interpret. There’s another challenge these systems rarely address: the gap between the ever-evolving body of scientific evidence and how quickly institutions respond to it. Research suggests it can take an average of 17 years for established findings to translate into clinical practice and regulatory guidance: a delay that’s particularly consequential in reproductive health, where timing matters and the stakes are high.

    This framework acknowledges that reality. When we classify evidence as “Established,” we mean the science is robust and consistent, not necessarily that regulators have caught up. This distinction matters, because waiting for formal consensus can mean waiting too long.

    I use these three tiers of evidence when I communicate research on the many factors impacting fertility, as a way to help you weigh evidence and risk with your personal values and goals, to support you to make clearer, more confident choices.

    You can see examples in our deep dives on phthalates, bisphenols, pesticides, lead, mercury, cadmium and arsenic. These, plus PFAS (forever chemicals), air pollution, organic solvents and more are incorporated in our Fertility Fit™ Method: a research-directed system that deploys six proprietary tools in sequence to help you uncover and address the hidden environmental factors most likely to be affecting your fertility, without overwhelm (or losing your sense of humour in the process).

    If you’d like to assess your own levels of exposure to environmental pollutants and toxins with Established and Indicated links to fertility, take the free Environmental Fertility Check (the first of our six proprietary tools). 

    If you’ve completed the Environmental Fertility Check, you might be wondering how your environmental exposure picture fits into the broader puzzle of factors that may be impacting your fertility. That’s exactly what a Define Your Preconception Strategy consultation is for: a clear-eyed, research-directed review of where you are and where to focus next. I’ll help you dig into your Check results and understand how relevant these environmental pieces may be within the wider picture of factors that research suggests impact fertility. You’ll leave with a clear view of the areas you can change to create healthier conditions for conception and pregnancy, and a direction that feels doable and genuinely yours. Book your consultation.

    If you’re a health practitioner reading this: we’re developing a short program covering the most important reproductive toxicant exposures to understand, how to test for the relevant markers, and how you may be able to support patients from a clinical perspective as they identify and reduce their exposures. Learn more.